Overview of: Medicines and Healthcare products Regulatory Agency. Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management. Drug Safety Update 2022;16(4): 1.
Keywords: Drug-Related Side Effects and Adverse Reactions; Health Care Quality, Access, and Evaluation.
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.